Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the Self-Expanding Medtronic CoreValve Prosthesis Without Predilation in Patients With Severely IMPaired Left-VentrIcular Ejection Fraction for TAVI Trial - The SIMPLIFy TAVI Trial

NCT01539746 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT01539746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01539746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the Self-Expanding Medtronic CoreValve Prosthesis Without Predilation in Patients With Severely IMPaired Left-VentrIcular Ejection Fraction for TAVI Trial - The SIMPLIFy TAVI Trial
Lead sponsor
University Hospital, Bonn
Phase
Not applicable
Overall status
Completed
Start date
January 9, 2013
Completion date
November 22, 2019
Enrollment
110 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, high-risk patients, left ventricular function systolic dysfunction, transcatheter aortic valve implantation